ALLY

<div class="textg" style="text-align: justify; font-weight: lighter; line-height: 1.3em; font-size: 15px; border-radius: 3px; color: #80909a; padding: 10px; background-color: #F4F6F9; margin-bottom: 15px;">
 Neither the author, Tim Fries, nor this website, The Tokenist, provide financial advice. Please consult our&nbsp;<a href="https://tokenist.com/terms-of-service/" style="text-decoration:underline;color:#3c7b7b" target="_blank" rel="noreferrer noopener" class="deco-link">website policy</a>&nbsp;prior to making financial decisions.
</div> 
<p class="has-drop-cap">In a detailed performance overview, LENSAR Inc. (Nasdaq: LNSR), a leader in advanced femtosecond laser solutions for cataract surgery, has reported its<a aria-label=" fourth quarter and full-year (opens in a new tab)" href="https://ir.lensar.com/news/news-details/2024/LENSAR-Reports-Fourth-Quarter-and-Full-Year-2023-Results-and-Provides-Business-Update/default.aspx" target="_blank" rel="noreferrer noopener nofollow" class="deco-link"> fourth quarter and full-year</a> 2023 results, showcasing significant achievements and strategic directions for the future. </p> 
<p>LENSAR’s fourth quarter of 2023 was a period of robust growth and operational success. The company’s total revenue saw an 18% increase compared to the same quarter in the previous year, amounting to $12.1 million. <br><br>This growth was primarily fueled by the sales and procedure volumes of the ALLY System, LENSAR’s flagship femtosecond laser cataract surgery technology. The company successfully placed 44 ALLY Adaptive Cataract Treatment Systems throughout the year, surpassing the target of 30 and significantly expanding the installed base to 54, with a backlog of 9 additional systems. </p> 
<h3 id="lensar-inc-outperforms-revenue-expectations-in-q4">LENSAR Inc. Outperforms Revenue Expectations in Q4</h3> 
<p>Compared to pre-set expectations for the quarter, LENSAR’s performance indicates a notable achievement. Analysts had projected earnings per share (<a href="https://tokenist.com/investing/fundamental-analysis-stocks/" rel="dofollow" class="deco-link">EPS</a>) of -$0.22 and revenue of $11.98 million for the quarter. <br><br>The actual revenue of $12.1 million slightly exceeded these expectations, underscoring the company’s capability to surpass financial forecasts. However, the net loss for the quarter was $3.9 million, or ($0.35) per share, which was deeper than the anticipated EPS. This discrepancy highlights the challenges in balancing operational expansion with financial management, particularly in a competitive and innovation-driven market.</p> 
<div class="cta-referral"> 
 <img src="https://tokenist.com/wp-content/themes/thetokenist/assets/img/del/cta-referral-1.png" alt="" class="cta-referral__img" loading="lazy" decoding="async"> 
 <div class="cta-referral__text"> 
  <p>Join our&nbsp;<a href="https://t.me/thetokenist" target="_blank" rel="noreferrer noopener nofollow" class="deco-link">Telegram group&nbsp;and never miss a breaking story.</a></p> 
 </div> 
</div> 
<h3 id="guidance">Guidance</h3> 
<p>LENSAR remains focused on broadening its market reach and solidifying its leadership in the cataract surgery technology domain. The company is working towards securing additional regulatory approvals outside the U.S., with plans to launch in select international markets in 2024, contingent on regulatory clearances. <br><br>This strategic move is expected to drive further growth and expand LENSAR’s global footprint. Additionally, the company projects its recurring revenue base, excluding any contribution from the South Korean market, to exceed $33 million going into 2024. This projection reflects confidence in the sustained demand for LENSAR’s technologies and the potential for continued revenue growth.</p> <iframe src="https://tokenist.substack.com/embed" width="100%" height="320" style="border:1px solid #EEE; background:white;" frameborder="0" scrolling="no"></iframe> 
<p><em>Disclaimer: The author does not hold or have a position in any securities discussed in the article.</em></p> 
<h3 id="br"><br></h3> 
<p>The post <a rel="nofollow" href="https://tokenist.com/lensar-inc-lnsr-reports-18-revenue-growth-in-q4-surpasses-ally-system-targets/">LENSAR Inc. (LNSR) Reports 18% Revenue Growth in Q4, Surpasses ALLY System Targets</a> appeared first on <a rel="nofollow" href="https://tokenist.com">Tokenist</a>.</p>

LENSAR Inc. (LNSR) Reports 18% Revenue Growth in Q4, Surpasses ALLY System Targets

目次

Tokenist

2024年3月4日公開の他の記事

Hong Kong Watchdog Cracks Down on Sham Crypto Sites

Ethereum vs Solana: Latest Upgrades Heat Up Supremacy Battle

Toncoin (TON) Soars Following Telegram’s Latest Announcement; Cosmos (ATOM) Defies Expectations; ...

Demigod NFTs: Army of Fortune’s Next Generation of Gaming NFTs

Rising Interest and Optimism Fuel NFT Projects, Bolstering Bitcoin and Milady Maker

SingularityNET (AGIX) Bounces Back After Major Token Unlock; Pepe (PEPE) Skyrockets; InQubeta (QU...

ニュースレターを購読して暗号資産の最新情報を毎日入手！